Anti-tumor activity of icotinib (BPI-2009H) and BPI-403B in the BxPC-3 pancreatic cancer cell line

被引：0
|
作者：
Wilde, Victoria Lynn [1 ]
Zhang, Don [1 ]
Peng, Jirong [1 ]
Green, Michael A. [1 ]
Greco, Michael N. [1 ]
Costanzo, Michael [1 ]
机构：
[1] Beta Pharma Inc, Princeton, NJ USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2592
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2592
引用
收藏
页数：2
相关论文
共 11 条
  • [1] Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line
    Ying-Ying Lu
    World Journal of Gastroenterology, 2008, (35) : 5403 - 5411
  • [2] Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line
    Lu, Ying-Ying
    Jing, Da-Dao
    Xu, Ming
    Wu, Kai
    Wang, Xing-Peng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (35) : 5403 - 5411
  • [3] Ubiquitin Ligase Cbl-b Is Involved in Icotinib (BPI-2009H)-Induced Apoptosis and G1 Phase Arrest of EGFR Mutation-Positive Non-Small-Cell Lung Cancer
    Mu, Xiaodong
    Zhang, Ye
    Qu, Xiujuan
    Hou, Kezuo
    Kang, Jian
    Hu, Xuejun
    Liu, Yunpeng
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [4] A phase I/IIa study of icotinib hydrochloride (BPI-2009H), an oral epidermal growth factor receptor tyrosine kinases inhibitor, in patients with advanced non-small-cell lung cancer and other solid tumors
    Zhao, Q.
    Zhou, J.
    Shentu, J.
    Wu, L.
    Xu, N.
    Tan, F.
    Wang, Y.
    Yang, D.
    EJC SUPPLEMENTS, 2009, 7 (03): : 22 - 22
  • [5] Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-κB in BxPC-3 pancreatic cancer cell line
    Li, YW
    Ellis, KL
    Ali, S
    El-Rayes, BF
    Nedeljkovic-Kurepa, A
    Kucuk, O
    Philip, PA
    Sarkar, FH
    PANCREAS, 2004, 28 (04) : E90 - E95
  • [6] Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway
    Zhang, Mingjie
    Ding, Guoping
    Zhou, Liangjing
    Shen, Tao
    Xu, Xiaodong
    Zhao, Ting
    Jia, Shengnan
    Cao, LiPing
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2018, 38 (09): : 413 - 422
  • [7] Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line
    Liu, Qun
    Tan, Jingyu
    Zhao, Zhenguo
    Li, Ruijun
    Zheng, Luyu
    Chen, Xiangyu
    Li, Lina
    Dong, Xichen
    Wen, Tao
    Liu, Jian
    BIOMEDICINES, 2023, 11 (01)
  • [8] Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response
    Chen, Cheng
    Shen, Yu
    Qu, Qiu-Xia
    Chen, Xu-Qin
    Zhang, Xue-Guang
    Huang, Jian-An
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (01) : 96 - 102
  • [9] The anti-tumor activity of zoledronic acid and synergistic effect of zoledronic acid combination with docetaxel on prostate cancer cell line PC-3 in vitro at clinically achievable concentrations
    Shen, Zhiyuan
    Li, Shaojie
    Qian, Weiqing
    Sun, Zhongquan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 2181 - 2187
  • [10] B7-H3 (CD276) immunocytokines with target-cell restricted IL-15 activity for induction of anti-tumor immunity against leukemia and gastrointestinal tumors
    Schmied, B. J.
    Zekri-Metref, L.
    Maerklin, M.
    Pfluegler, M.
    Buehring, H. -J.
    Handgretinger, R.
    Kanz, L.
    Jung, G.
    Salih, H. R.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 240 - +
12